Cell surface activation of the alternative complement pathway by the fusion protein of measles virus

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1665-1673

  Devaux, Patricia ^a   Christiansen, Dale ^a   Plumet, Sébastien ^a   Gerlier, Denis ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CELL RECEPTOR; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR I; COMPLEMENT RECEPTOR; DECAY ACCELERATING FACTOR; HEMAGGLUTININ; MEMBRANE COFACTOR PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; CD46 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; IMMUNE SYSTEM; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; TARGET CELL; VIRUS INFECTIVITY; ANIMAL; CHO CELL; HAMSTER; HUMAN; PHYSIOLOGY;

MEASLES VIRUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; CHO CELLS; COMPLEMENT C3B; COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; CRICETINAE; HUMANS; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; VIRAL FUSION PROTEINS;

EID: 2942644452     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79880-0     Document Type: Article

References (58)

1. Adams, E. M., Brown, M. C., Nunge, M., Krych, M. & Atkinson, J. P. (1991). Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J Immunol 147, 3005-3011.
2. Aderem, A. & Ulevitch, R. J. (2000). Toll-like receptors in the induction of the innate immune response. Nature 406, 782-787.
3. Auwaerter, P. G., Rota, P. A., Elkins, W. R., Adams, R. J., DeLozier, T., Shi, Y., Bellini, W. J., Murphy, B. R. & Griffin, D. E. (1999). Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different Virus strains. J Infect Dis 180, 950-958.
4. Buchholz, C. J., Schneider, U., Devaux, P., Gerlier, D. & Cattaneo, R. (1996). Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol 70, 3716-3723.
5. Buchholz, C. J., Koller, D., Devaux, P., Mumenthaler, C., Schneider-Schaulies, J., Braun, W., Gerlier, D. & Cattaneo, R. (1997 . Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem 272, 22072-22079.
6. Caudwell, V., Porteu, F., Calender, A., Pangburn, M. K. & Halbwachs-Mecarelli, L. (1990). Complement alternative pathway activation and control on membranes of human lymphoid B cell lines. Eur J Immunol 20, 2643-2650.
7. Christiansen, D., Deléage, G. & Gerlier, D. (2000a). Evidence for distinct complement regulatory and measles virus binding sites on CD46 SCR2. Eur J Immunol 30, 3457-3462.
8. Christiansen, D., Loveland, B., Kyriakou, P., Lanteri, M., Rubinstein, E. & Gerlier, D. (2000b). Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation. Mol Immunol 37, 687-696.
9. Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C. & Fearon, D. T. (1996). C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348-350.
10. Devaux, P., Christiansen, D., Fontaine, M. & Gerlier, D. (1999). Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation. Eur J Immunol 29, 815-822.
11. Dierich, M. P., Ebenbichler, C. F., Marschang, P., Füst, G., Thielens, N. M. & Arlaud, G. J. (1993). HIV and human complement: mechanisms of interaction and biological implication. Immunol Today 14, 435-440.
12. Dörig, R. E., Marcil, A., Chopra, A. & Richardson, C. D. (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
13. Ebenbichler, C. F., Thielens, N. M., Vornhagen, R., Marschang, P., Arlaud, G. J. & Dierich, M. P. (1991). Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in thle transmembrane glycoprotein gp41. J Exp Med 174, 1417-1424.
14. Erlenhoefer, C., Wurzer, W. J., Löffler, S., Schneider-Schaulies, S., ter Meulen, V. & Schneider-Schaulies, J. (2001). CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol 75, 4499-4505.
15. Fayolle, J., Verrier, B., Buckland, R. & Wild, T. F. (1999). Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization. J Virol 73, 787-790.
16. Fearon, D. T. (2000). Innate immunity - beginning to fulfill its promise? Nat Immunol 1, 102-103.
17. Fugier-Vivier, I., Servet-Delprat, C., Rivailler, P., Rissoan, M. C., Liu, Y. J. & Rabourdin-Combe, C. (1997). Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186, 813-823.
18. Fulginiti, V. A., Eller, J. J., Downie, A. W. & Kempe, C. H. (1967). Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202, 1075-1080.
19. Griffin, D. E., Ward, B. J. & Esolen, L. M. (1994). Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 170, S24-31.
20. Harris, C. L., Spiller, O. B. & Morgan, B. P. (2000). Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities. Immunology 100, 462-470.
21. Hicks, J. T., Sullivan, J. L. & Albrecht, P. (1977). Immune responses during measles infection in immunosuppressed Rhesus monkeys. J Immunol 119, 1452-1456.
22. Hirsch, R. L., Griffin, D. E., Johnson, R. T., Cooper, S. J., Lindo de Soriano, I., Roedenbeck, S. & Vaisberg, A. (1984). Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 31, 1-12.
23. Iwata, K., Seya, T., Yanagi, Y., Pesando, J. M., Johnson, P. M., Okabe, M., Ueda, S., Ariga, H. & Nagasawa, S. (1995). Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem 270, 15148-15152.
24. Kapadia, S. B., Levine, B., Speck, S. H. & Virgin, H. W. T. (2002). Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 17, 143-155.
25. Karp, C. L. (1999). Measles: immunosuppression, interleukin-12, and complement receptors. Immunol Rev 168, 91-101.
26. Karp, C. L., Wysocka, M., Wahl, L. M., Aheam, J. M., Cuomo, P. J., Sherry, B., Trinchieri, G. & Griffin, D. (1996). Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231.
27. Kojima, A., Iwata, K., Seya, T., Matsumoto, M., Ariga, H., Atkinson, J. P. & Nagasawa, S. (1993). Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol 151, 1519-1527.
28. Krantic, S., Gimenez, C. & Rabourdin-Combe, C. (1995). Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 down regulation. J Gen Virol 76, 2793-2800.
29. Lecouturier, V., Fayolle, J., Caballero, M., Carabana, J., Celma, M. L., Fernandez-Munoz, R., Wild, T. F. & Buckland, R. (1996). Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J Virol 70, 4200-4204.
30. Liszewski, M. K., Post, T. W. & Atkinson, J. P. (1991). Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9, 431-455.
31. Liszewski, M. K., Leung, M., Cui, W., Subramanian, V. B., Parkinson, J., Barlow, P., Manchester, M. & Atkinson, J. P. (2000). Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J Biol Chem 275, 37692-37701.
32. Lozahic, S., Christiansen, D., Manié, S., Gerlier, D., Billard, M., Boucheix, C. & Rubinstein, E. (2000). CD46 associates with multiple β1 integrins and tetraspans. Eur J Immunol 30, 900-907.
33. Manchester, M., Valsamakis, A., Kaufman, R., Liszewski, M. K., Alvarez, J., Atkinson, J. P., Lublin, D. M. & Oldstone, M. B. A. (1995). Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci U S A 92, 2303-2307.
34. Manie, S. N., Debreyne, S., Vincent, S. & Gerlier, D. (2000). Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol 74, 305-311.
35. Mold, C., Bradt, B. M., Nemerow, G. R. & Cooper, N. R. (1988). Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med 168, 949-969.
36. Murakami, Y., Seya, T., Kurita, M., Fukui, A., Ueda, S. & Nagasawa, S. (1998). Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus. Biochem 1330, 1351-1359.
37. Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C. & Gerlier, D. (1993a). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67, 6025-6032.
38. Naniche, D., Wild, T. F., Rabourdin-Combe, C. & Gerlier, D. (1993b). Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J Gen Virol 74, 1073-1079.
39. Oglesby, T. J., Allen, C. J., Liszewski, M. K., White, D. J. & Atkinson, J. P. (1992). Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 175, 1547-1551.
40. Richardson, C. D. & Choppin, P. W. (1983). Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology 131, 518-532.
41. Sahu, A. & Lambris, J. D. (2001). Structure and biology of complement C3, a connecting link between innate and acquired immunity. Immunol Rev 180, 35-48.
42. Schneider-Schaulies, J., Dunster, L. M., Kobune, F., Rima, B. & ter Meulen, V. (1995). Differential downregulation of CD46 by measles virus strains. J Virol 69, 7257-7259.
43. Schnorr, J. J., Dunster, L. M., Nanan, R., Schneider-Schaulies, J., Schneider-Schaulies, S. & ter Meulen, V. (1995). Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur J Immunol 25, 976-984.
44. Seya, T. & Atkinson, J. P. (1989). Functional properties of membrane cofactor protein of complement. Biochem J 264, 581-588.
45. Sissons, J. G. P., Schreiber, R. D., Perrin, L. H., Cooper, N. R., Muller-Eberhard, H. J. & Oldstone, M. B. A. (1979). Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody. J Exp Med 150, 415-454.
46. Sissons, J. G. P., Oldstone, M. B. A. & Schreiber, R. D. (1980). Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. Proc Natl Acad Sci U S A 77, 559-562.
47. Solder, B. M., Schulz, T. F., Hengster, P., Lower, J., Larcher, C., Bitterlich, G., Kurth, R., Wachter, H. & Dierich, M. P. (1989). HIV and HIV-infected cells differentially activate the human complement system independent of antibody. Immunol Lett 22, 135-145.
48. Spiller, O. B. & Morgan, B. P. (1998). Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts. J Infect Dis 178, 1597-1603.
49. Stein, C. E., Birmingham, M., Kurian, M., Duclos, P. & Strebel, P. (2003). The global burden of measles in the year 2000 - a model that uses country-specific indicators. J Infect Dis 187, S8-14.
50. Tatsuo, H., Okuma, K., Tanaka, K., Ono, N., Minagawa, H., Takade, A., Matsuura, Y. & Yanagi, Y. (2000a). Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J Virol 74, 4139-4145.
51. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. (2000b). SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897.
52. Thieblemont, N., Haeffner-Cavaillon, N., Weiss, L., Maillet, F. & Kazatchkine, M. D. (1993). Complement activation by gp160 glycoprotein of HIV-1. AIDS Res Hum Retrovir 9, 229-233.
53. Thielens, N. M., Cseh, S., Thiel, S., Vorup-Jensen, T., Rossi, V., Jensenius, J. C. & Arlaud, G. J. (2001). Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol 166, 5068-5077.
54. Turner, M. W. (1998). Mannose-binding lectin (MBL) in health and disease. Immunobiology 199, 327-339.
55. Vincent, S., Gerlier, D. & Manie, S. N. (2000). Measles virus assembly within membrane rafts. J Virol 74, 9911-9915.
56. Xu, C., Mao, D., Holers, V. M., Palanca, B., Cheng, A. M. & Molina, H. (2000). A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287, 498-501.
57. Yamanouchi, K., Ohta, H., Kataoka, T., Kobune, F., Yoshikawa, Y. & Tokunaga, T. (1981). Suppression of delayed hypersensitivity by measles virus infection in guinea pigs. Jpn J Med Sci Biol 34, 81-94.
58. Yant, S., Hirano, A. & Wong, T. C. (1997). Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection. J Virol 71, 766-770.